143 related articles for article (PubMed ID: 33782098)
1. POT1 Regulates Proliferation and Confers Sexual Dimorphism in Glioma.
Jalali A; Yu K; Beechar V; Bosquez Huerta NA; Grichuk A; Mehra D; Lozzi B; Kong K; Scott KL; Rao G; Bainbridge MN; Bondy ML; Deneen B
Cancer Res; 2021 May; 81(10):2703-2713. PubMed ID: 33782098
[TBL] [Abstract][Full Text] [Related]
2.
Shen E; Xiu J; Lopez GY; Bentley R; Jalali A; Heimberger AB; Bainbridge MN; Bondy ML; Walsh KM
J Med Genet; 2020 Oct; 57(10):664-670. PubMed ID: 31937561
[TBL] [Abstract][Full Text] [Related]
3. Germline mutations in shelterin complex genes are associated with familial glioma.
Bainbridge MN; Armstrong GN; Gramatges MM; Bertuch AA; Jhangiani SN; Doddapaneni H; Lewis L; Tombrello J; Tsavachidis S; Liu Y; Jalali A; Plon SE; Lau CC; Parsons DW; Claus EB; Barnholtz-Sloan J; Il'yasova D; Schildkraut J; Ali-Osman F; Sadetzki S; Johansen C; Houlston RS; Jenkins RB; Lachance D; Olson SH; Bernstein JL; Merrell RT; Wrensch MR; Walsh KM; Davis FG; Lai R; Shete S; Aldape K; Amos CI; Thompson PA; Muzny DM; Gibbs RA; Melin BS; Bondy ML;
J Natl Cancer Inst; 2015 Jan; 107(1):384. PubMed ID: 25482530
[TBL] [Abstract][Full Text] [Related]
4. A mouse model for Li-Fraumeni-Like Syndrome with cardiac angiosarcomas associated to POT1 mutations.
Martínez P; Sánchez-Vázquez R; Ferrara-Romeo I; Serrano R; Flores JM; Blasco MA
PLoS Genet; 2022 Jun; 18(6):e1010260. PubMed ID: 35727838
[TBL] [Abstract][Full Text] [Related]
5. The wide spectrum of POT1 gene variants correlates with multiple cancer types.
Calvete O; Garcia-Pavia P; Domínguez F; Bougeard G; Kunze K; Braeuninger A; Teule A; Lasa A; Ramón Y Cajal T; Llort G; Fernández V; Lázaro C; Urioste M; Benitez J
Eur J Hum Genet; 2017 Nov; 25(11):1278-1281. PubMed ID: 28853721
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Cancer-Predisposing Germline
Jajosky AN; Mitchell AL; Akgul M; Shetty S; Yoest JM; Gerson SL; Sadri N; Oduro KA
Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456397
[TBL] [Abstract][Full Text] [Related]
7. Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood.
Michler P; Schedel A; Witschas M; Friedrich UA; Wagener R; Mehtonen J; Brozou T; Menzel M; Walter C; Nabi D; Pearce G; Erlacher M; Göhring G; Dugas M; Heinäniemi M; Borkhardt A; Stölzel F; Hauer J; Auer F
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769003
[TBL] [Abstract][Full Text] [Related]
8. Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.
Orois A; Badenas C; Reverter JL; López V; Potrony M; Mora M; Halperin I; Oriola J
Horm Cancer; 2020 Apr; 11(2):111-116. PubMed ID: 32172474
[TBL] [Abstract][Full Text] [Related]
9. Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.
Gu P; Wang Y; Bisht KK; Wu L; Kukova L; Smith EM; Xiao Y; Bailey SM; Lei M; Nandakumar J; Chang S
Oncogene; 2017 Apr; 36(14):1939-1951. PubMed ID: 27869160
[TBL] [Abstract][Full Text] [Related]
10. Telomere Replication Stress Induced by POT1 Inactivation Accelerates Tumorigenesis.
Pinzaru AM; Hom RA; Beal A; Phillips AF; Ni E; Cardozo T; Nair N; Choi J; Wuttke DS; Sfeir A; Denchi EL
Cell Rep; 2016 Jun; 15(10):2170-2184. PubMed ID: 27239034
[TBL] [Abstract][Full Text] [Related]
11. POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas.
Calvete O; Garcia-Pavia P; Domínguez F; Mosteiro L; Pérez-Cabornero L; Cantalapiedra D; Zorio E; Ramón Y Cajal T; Crespo-Leiro MG; Teulé Á; Lázaro C; Morente MM; Urioste M; Benitez J
J Am Heart Assoc; 2019 Sep; 8(18):e012875. PubMed ID: 31510873
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated POT1 mutations lead to telomere elongation without induction of a DNA damage response.
Kim WT; Hennick K; Johnson J; Finnerty B; Choo S; Short SB; Drubin C; Forster R; McMaster ML; Hockemeyer D
EMBO J; 2021 Jun; 40(12):e107346. PubMed ID: 33934394
[TBL] [Abstract][Full Text] [Related]
13. Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres.
Hockemeyer D; Daniels JP; Takai H; de Lange T
Cell; 2006 Jul; 126(1):63-77. PubMed ID: 16839877
[TBL] [Abstract][Full Text] [Related]
14. Time-Dependent Effects of POT1 Knockdown on Proliferation, Tumorigenicity, and HDACi Response of SK-OV3 Ovarian Cancer Cells.
Zhou H; Mondal A; Dakic A; Alhawas L; Liu X; He Z
Biomed Res Int; 2018; 2018():7184253. PubMed ID: 29546066
[TBL] [Abstract][Full Text] [Related]
15. TRF2 promotes dynamic and stepwise looping of POT1 bound telomeric overhang.
Paul T; Liou W; Cai X; Opresko PL; Myong S
Nucleic Acids Res; 2021 Dec; 49(21):12377-12393. PubMed ID: 34850123
[TBL] [Abstract][Full Text] [Related]
16. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD; Aguilera P; Carrera C; Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S
Br J Dermatol; 2019 Jul; 181(1):105-113. PubMed ID: 30451293
[TBL] [Abstract][Full Text] [Related]
17. POT1: a genetic link for familial glioma.
Bagcchi S
Lancet Oncol; 2015 Jan; 16(1):e12. PubMed ID: 25524796
[No Abstract] [Full Text] [Related]
18. RPA and POT1: friends or foes at telomeres?
Flynn RL; Chang S; Zou L
Cell Cycle; 2012 Feb; 11(4):652-7. PubMed ID: 22373525
[TBL] [Abstract][Full Text] [Related]
19. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.
Butler KS; Hines WC; Heaphy CM; Griffith JK
Cancer Med; 2012 Oct; 1(2):165-75. PubMed ID: 23342266
[TBL] [Abstract][Full Text] [Related]
20. Profile of POT1 as telomerase shelterin component discriminatesbetween cervical cancer and normal cervical cells.
Wijaya AB; Hidayatullah F; Setyabudhi VV; Pahlevi FR; Indra R; Nurseta T
Turk J Med Sci; 2017 Apr; 47(2):417-423. PubMed ID: 28425274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
